Improved Response Rate with Bortezomib Consolidation After High Dose Melphalan: First Results of a Nordic Myeloma Study Group Randomized Phase III Trial

Ulf-Henrik Mellqvist, Jan Westin, Peter Gimsing, Oyvind Hjertner, Stig Lenhoff, Edward Laane, Kari Remes, Hlif Steingrimsdottir, Niels Abildgaard, Lucia Ahlberg, Kristina Carlsson, Inge Marie Dahl, Karin Forsberg, Tobias Gedde-Dahl, Henrik Gregersen, Astrid Gruber, Nina Guldbrandsen, Einar Haukas, Olle Linder, Hareth NahiIngerid Nesthus, Nilsaage Toffner-Clausen, Raija Silvennoinen, Niels Frost Andersen, Ingemar Turesson, Anders Waage

Research output: Contribution to journalPublished meeting abstractpeer-review

Original languageEnglish
Pages (from-to)221-221
JournalBlood
Volume114
Issue number22
Publication statusPublished - 2009
Event51st Annual Meeting of the American-Society-of-Hematology - New Orleans, LA
Duration: 2009 Dec 52009 Dec 8

Subject classification (UKÄ)

  • Hematology

Cite this